Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Peter J. H. Smak Gregoor"'
Autor:
Shiuw H Ho-Han, Eric F.H. van Bommel, Pieter J. Westenend, Mark A van der Zijden, Tadek R. Hendriksz, Peter J H Smak Gregoor
Publikováno v:
Acta Oncologica. 58:901-905
Erdheim–Chester Disease (ECD) is a rare, non-Langerhans histiocytosis, characterized by the accumulation of foamy macrophages, chronic inflammation, fibrosis and organ failure [1,2]. Interferon alf...
Publikováno v:
Clinical Kidney Journal
Autor:
Willij C. Zuidema, Jan J. V. Busschbach, Robert W. Nette, A.E. Luchtenburg, René M. A. van den Dorpel, Sohal Y. Ismail, Reinier Timman, Peter J. H. Smak Gregoor, Lotte Timmerman, Willem Weimar, Emma K. Massey
Publikováno v:
Transplant International, 26(12), 1164-1172. Wiley-Blackwell Publishing Ltd
Knowledge is a prerequisite for promoting well-informed decision-making. Nevertheless, there is no validated and standardized test to assess the level of knowledge among renal patients regarding kidney disease and all treatment options. Therefore, th
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 159
The differential diagnosis of nephrotic syndrome is diverse. Systemic conditions and medication such as NSAIDs can cause this syndrome.A 33-year-old male with Crohn's disease for which he was receiving adalimumab noticed he was gaining weight and had
Autor:
Ilse P. van der Heiden, Peter J. H. Smak Gregoor, Teun van Gelder, Jan Lindemans, Ron H.N. van Schaik, Marloes van der Werf, Dennis A. Hesselink, Willem Weimar
Publikováno v:
Clinical Pharmacology & Therapeutics, 74, 245-254. Wiley-Blackwell
Background The calcineurin inhibitors cyclosporine (INN, ciclosporin) and tacrolimus have a narrow therapeutic index and show considerable interindividual variability in their pharmacokinetics. The low oral bioavailability of calcineurin inhibitors i
Autor:
Teun van Gelder, Peter J. H. Smak Gregoor, M. Wabbijn, Iza C. van Riemsdijk, Dennis A. Hesselink, Willem Weimar, Ewout W. Steyerberg, Hien Ngyuen
Publikováno v:
British Journal of Clinical Pharmacology, 56, 327-330. Wiley-Blackwell Publishing Ltd
Aims To evaluate the effect of corticosteroids on tacrolimus pharmacokinetics. Methods In a randomized trial, kidney transplant recipients were treated with tacrolimus and mycophenolate mofetil with either daclizumab (n = 31) or 3 months of prednison
Autor:
R. J. Hene, Peter J. H. Smak Gregoor, Luuk B. Hilbrands, Judith A. Kal-van Gestel, Joke I. Roodnat, Arjan D. van Zuilen, Andries J. Hoitsma, Cynthia Konijn, Teun van Gelder, Ruud G. L. de Sévaux, Willem Weimar
Publikováno v:
Transplantation, 98, 47-53
Transplantation, 98(1), 47-53. Lippincott Williams & Wilkins
Transplantation, 98, 1, pp. 47-53
Transplantation, 98(1), 47-53. Lippincott Williams & Wilkins
Transplantation, 98, 1, pp. 47-53
Item does not contain fulltext BACKGROUND: Calcineurin inhibitors (CNIs) are essential immunosuppressive drugs after renal transplantation. Because of nephrotoxicity, withdrawal has been a challenge since their introduction. METHODS: A randomized mul
Publikováno v:
Netherlands Journal of Medicine, 57(6), 233-246. Van Zuiden Communications
Mycophenolate mofetil is a new immunosuppressive drug, exhibiting its effect through inhibition of proliferation of T- and B-lymphocytes. Superior efficacy of mycophenolate mofetil compared to azathioprine, in combination with cyclosporine and predni
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 157(24)
Renal function is currently estimated using the Modification of Diet in Renal Disease (MDRD) formula, which is partly based on the serum creatinine level. Patients with impaired renal function are referred to nephrologists in accordance with the Dutc
Autor:
Willem Weimar, Emma K. Massey, Robert Zietse, Peter J. H. Smak Gregoor, Robert W. Nette, Jan J. Busschbach, Anthony van Kooij, Medard Hilhorst, Marinus A. van den Dorpel, Willij C. Zuidema
Publikováno v:
Journal of Medical Ethics, 37(11), 677-681. BMJ Publishing Group
In this article, an ethical analysis of an educational programme on renal replacement therapy options for patients and their social network is presented. The two main spearheads of this approach are: (1) offering an educational programme on all renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2172e3348ff9c0958d9006e688276936
https://pure.eur.nl/en/publications/6c71e3b6-f1cb-4590-aa2f-795f4b83af46
https://pure.eur.nl/en/publications/6c71e3b6-f1cb-4590-aa2f-795f4b83af46